Viral miRNA-mediated activation of hyaluronan production as a drug target against COVID-19

被引：0
|
作者：
Shuai Yang [1 ,2 ]
Lu Chen [1 ,2 ]
Ying Tong [1 ,2 ]
Wenqiang Yu [1 ,2 ]
机构：
[1] Laboratory of RNA Epigenetics, Institutes of Biomedical Sciences & Shanghai Public Health Clinical Center & Department of General Surgery, Huashan Hospital, Cancer Metastasis Institute, Shanghai Medical College, Fudan University
[2] Shanghai Key Laboratory of Medical Epigenetics
来源：
ActaPharmaceuticaSinicaB | 2022年 / 12卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
The global coronavirus disease 2019(COVID-19) pandemic has caused more than 6.1 million deaths until March 24, 2022, as reported by the World Health Organization(WHO). Recently,breakthrough infections have appeared in individuals fully vaccinated against SARS-Co V-21, which could be attributed to the rapid mutation of the RNA virus2. Currently, following the Delta variant, the Omicron variant of SARS-Co V-2 is increasingly becoming the dominant epidemic strain in the world.
引用
收藏
页码：3195 / 3197
页数：3
相关论文
共 50 条
  • [11] The application of direct viral cytopathic hypothesis to design drug trials in the battle against COVID-19
    Mohammad Ali Ashraf
    Alireza Sherafat
    Alieh Pourdast
    Pershang Nazemi
    Minoo Mohraz
    DARU Journal of Pharmaceutical Sciences, 2020, 28 : 813 - 814
  • [12] The application of direct viral cytopathic hypothesis to design drug trials in the battle against COVID-19
    Ashraf, Mohammad Ali
    Sherafat, Alireza
    Pourdast, Alieh
    Nazemi, Pershang
    Mohraz, Minoo
    DARU-JOURNAL OF PHARMACEUTICAL SCIENCES, 2020, 28 (02) : 813 - 814
  • [13] The role of growth factor receptors in viral infections: An opportunity for drug repurposing against emerging viral diseases such as COVID-19?
    Hondermarck, Hubert
    Bartlett, Nathan W.
    Nurcombe, Victor
    FASEB BIOADVANCES, 2020, 2 (05) : 296 - 303
  • [14] TARGET BASED PHARMACOLOGICAL APPROACHES FOR DRUG DEVELOPMENT AGAINST NOVEL CORONA VIRUS (COVID-19)
    Hoda, Quaisul
    Fatma, Askary
    Pahwa, Shilpa
    Gupta, Chitra
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2020, 11 (11): : 5284 - 5289
  • [15] COVID-19: lambda interferon against viral load and hyperinflammation
    Andreakos, Evangelos
    Tsiodras, Sotirios
    EMBO MOLECULAR MEDICINE, 2020, 12 (06)
  • [16] Immune-mediated approaches against COVID-19
    Florindo, Helena F.
    Kleiner, Ron
    Vaskovich-Koubi, Daniella
    Acurcio, Rita C.
    Carreira, Barbara
    Yeini, Eilam
    Tiram, Galia
    Liubomirski, Yulia
    Satchi-Fainaro, Ronit
    NATURE NANOTECHNOLOGY, 2020, 15 (08) : 630 - 645
  • [17] Immune-mediated approaches against COVID-19
    Helena F. Florindo
    Ron Kleiner
    Daniella Vaskovich-Koubi
    Rita C. Acúrcio
    Barbara Carreira
    Eilam Yeini
    Galia Tiram
    Yulia Liubomirski
    Ronit Satchi-Fainaro
    Nature Nanotechnology, 2020, 15 : 630 - 645
  • [18] Afghanistan: vaccinate drug users against COVID-19
    Attaullah Ahmadi
    Blaise Ntacyabukura
    Don Eliseo Lucero-Prisno III
    Nature, 2021, 593 : 195 - 195
  • [19] Afghanistan: vaccinate drug users against COVID-19
    Ahmadi, Attaullah
    Ntacyabukura, Blaise
    Lucero-Prisno, Don Eliseo, III
    NATURE, 2021, 593 (7858) : 195 - 195
  • [20] The roles of innate and adaptive immunity in inactivated viral vaccination-mediated protection against COVID-19
    Yu, Shanhe
    Chen, Shijun
    Zhu, Jiang
    Qu, Jieming
    CLINICAL AND TRANSLATIONAL MEDICINE, 2024, 14 (01):
12345